HUMAN IMMUNOGLOBULIN G

HUMAN IMMUNOGLOBULIN G was reported 20933 times

HUMAN IMMUNOGLOBULIN G is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALLERGY TO IMMUNOGLOBULIN THERAPY 50 0.4587
1 INSPIRATORY CAPACITY DECREASED 78 0.2816
2 BLOOD IMMUNOGLOBULIN G ABNORMAL 45 0.2695
3 AMAUROSIS FUGAX 212 0.1968
4 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 62 0.1845
5 INFUSION SITE MASS 185 0.1702
6 INFUSION SITE DISCHARGE 285 0.1624
7 INFUSION SITE BRUISING 336 0.1554
8 INFUSION SITE SCAR 65 0.1467
9 ANKLE ARTHROPLASTY 45 0.1240
10 SHORT STATURE 31 0.1183
11 STIFF PERSON SYNDROME 38 0.1095
12 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 26 0.1074
13 CORONARY ARTERY ANEURYSM 25 0.1064
14 INFUSION SITE PRURITUS 335 0.1061
15 INFUSION SITE URTICARIA 71 0.1060
16 COOMBS DIRECT TEST POSITIVE 33 0.1058
17 BLOOD IMMUNOGLOBULIN G DECREASED 262 0.1056
18 TRANSFUSION-RELATED ACUTE LUNG INJURY 32 0.1039
19 IMMUNOGLOBULINS ABNORMAL 27 0.1034
20 BLOOD IMMUNOGLOBULIN A DECREASED 67 0.1029
21 INFUSION SITE HAEMORRHAGE 327 0.0993
22 INFUSION SITE DISCOMFORT 102 0.0984
23 IMMUNOGLOBULINS DECREASED 130 0.0946
24 BODY HEIGHT BELOW NORMAL 60 0.0933
25 JOINT DESTRUCTION 145 0.0932
26 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 125 0.0869
27 INFUSION SITE SWELLING 538 0.0854
28 DEVICE INFUSION ISSUE 210 0.0846
29 INCORRECT DRUG ADMINISTRATION RATE 359 0.0843
30 IMMUNISATION REACTION 58 0.0806
31 BONE DENSITY INCREASED 26 0.0652
32 BLOOD IMMUNOGLOBULIN M DECREASED 63 0.0628
33 DEATH OF RELATIVE 25 0.0616
34 INFUSION SITE RASH 83 0.0605
35 INSURANCE ISSUE 909 0.0594
36 INFUSION SITE ERYTHEMA 501 0.0594
37 MULTIPLE ALLERGIES 453 0.0577
38 BLOOD IMMUNOGLOBULIN G INCREASED 70 0.0576
39 SMOOTH MUSCLE CELL NEOPLASM 24 0.0574
40 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 26 0.0566
41 POST-ACUTE COVID-19 SYNDROME 69 0.0557
42 SPUTUM PURULENT 36 0.0547
43 INFUSION SITE PAIN 693 0.0537
44 INFUSION SITE IRRITATION 68 0.0529
45 COVID-19 IMMUNISATION 42 0.0503
46 INFUSION SITE DISCOLOURATION 43 0.0489
47 MENINGITIS ASEPTIC 218 0.0485
48 THROMBOCYTOPENIA NEONATAL 20 0.0475
49 IMMUNOGLOBULINS INCREASED 22 0.0472
50 ALLERGY TO PLANTS 21 0.0460
51 EHLERS-DANLOS SYNDROME 21 0.0452
52 ANTIBODY TEST POSITIVE 73 0.0439
53 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 101 0.0438
54 URINARY TRACT DISORDER 195 0.0433
55 MYASTHENIC SYNDROME 33 0.0426
56 INFECTED BITE 36 0.0424
57 ALLERGIC SINUSITIS 36 0.0420
58 INFUSION SITE OEDEMA 35 0.0419
59 INFUSION SITE REACTION 124 0.0415
60 NOROVIRUS INFECTION 58 0.0402
61 SINUSITIS BACTERIAL 41 0.0389
62 INFUSION SITE WARMTH 46 0.0375
63 POLYARTHRITIS 195 0.0370
64 POOR VENOUS ACCESS 380 0.0367
65 SEASONAL ALLERGY 475 0.0335
66 MYASTHENIA GRAVIS CRISIS 49 0.0330
67 ENCEPHALITIS AUTOIMMUNE 43 0.0327
68 HAND DERMATITIS 22 0.0317
69 INFUSION SITE EXTRAVASATION 187 0.0300
70 INFUSION SITE NODULE 28 0.0291
71 OBSTRUCTION 116 0.0290
72 GASTROINTESTINAL VIRAL INFECTION 30 0.0288
73 SECONDARY IMMUNODEFICIENCY 35 0.0288
74 HAEMORRHAGIC STROKE 225 0.0288
75 JUVENILE IDIOPATHIC ARTHRITIS 70 0.0286
76 INFUSION SITE INDURATION 42 0.0283
77 IMMUNE THROMBOCYTOPENIA 129 0.0281
78 DRUG SPECIFIC ANTIBODY 38 0.0277
79 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 73 0.0274
80 MAST CELL ACTIVATION SYNDROME 38 0.0271
81 CROUP INFECTIOUS 21 0.0266
82 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 36 0.0266
83 TRANSFUSION REACTION 23 0.0262
84 PNEUMONIA PSEUDOMONAL 40 0.0261
85 CEREBRAL VENOUS SINUS THROMBOSIS 22 0.0260
86 DERMATITIS CONTACT 294 0.0258
87 CHRONIC SINUSITIS 93 0.0248
88 DERMATOMYOSITIS 61 0.0241
89 DRUG TOLERANCE 121 0.0239
90 MYASTHENIA GRAVIS 189 0.0234
91 WHEELCHAIR USER 104 0.0234
92 PRODUCT DISTRIBUTION ISSUE 213 0.0229
93 IMMUNE-MEDIATED MYOSITIS 63 0.0228
94 RESPIRATORY TRACT INFECTION VIRAL 53 0.0227
95 OCULAR DISCOMFORT 244 0.0217
96 GASTROENTERITIS VIRAL 370 0.0205
97 VACCINATION FAILURE 34 0.0204
98 RENAL TRANSPLANT FAILURE 20 0.0202
99 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 26 0.0197
100 RESPIRATORY TRACT INFECTION 513 0.0197
101 ALLERGY TO CHEMICALS 24 0.0193
102 CYTOMEGALOVIRUS VIRAEMIA 85 0.0191
103 BRONCHIECTASIS 127 0.0188
104 ADRENAL INSUFFICIENCY 228 0.0188
105 SINUSITIS 1900 0.0185
106 VEIN RUPTURE 31 0.0185
107 SHOULDER FRACTURE 30 0.0183
108 EAR INFECTION 484 0.0182
109 RHEUMATOID FACTOR POSITIVE 104 0.0180
110 PARAINFLUENZAE VIRUS INFECTION 27 0.0177
111 MULTIPLE-DRUG RESISTANCE 55 0.0177
112 RESPIRATORY SYNCYTIAL VIRUS INFECTION 154 0.0177
113 HAEMOLYTIC ANAEMIA 151 0.0168
114 GENERALISED OEDEMA 208 0.0168
115 HAEMATOLOGICAL INFECTION 41 0.0167
116 CYTOMEGALOVIRUS INFECTION REACTIVATION 74 0.0167
117 DISCHARGE 23 0.0166
118 VASCULAR DEVICE INFECTION 75 0.0165
119 ARTHROPOD STING 27 0.0162
120 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 38 0.0162
121 LYME DISEASE 54 0.0162
122 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 885 0.0161
123 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 117 0.0156
124 COVID-19 PNEUMONIA 183 0.0155
125 AUTOIMMUNE HAEMOLYTIC ANAEMIA 53 0.0154
126 PHARYNGITIS STREPTOCOCCAL 164 0.0151
127 ASPERGILLUS INFECTION 99 0.0151
128 UPPER RESPIRATORY TRACT INFECTION 694 0.0150
129 RHINOVIRUS INFECTION 58 0.0149
130 EPSTEIN-BARR VIRUS INFECTION 93 0.0149
131 HEAD DISCOMFORT 262 0.0148
132 SKIN INFECTION 166 0.0148
133 ANIMAL BITE 39 0.0146
134 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 104 0.0145
135 IMMUNODEFICIENCY 216 0.0145
136 EYE CONTUSION 30 0.0142
137 STREPTOCOCCAL INFECTION 79 0.0142
138 HYPOGAMMAGLOBULINAEMIA 93 0.0141
139 BODY TEMPERATURE ABNORMAL 26 0.0141
140 SKIN LACERATION 152 0.0140
141 AUTOIMMUNE DISORDER 136 0.0139
142 GASTROINTESTINAL INFECTION 124 0.0138
143 JC VIRUS INFECTION 22 0.0138
144 SUSPECTED COVID-19 45 0.0136
145 PNEUMONIA BACTERIAL 124 0.0135
146 TOOTH INFECTION 177 0.0134
147 VIRAL INFECTION 444 0.0133
148 SINUS DISORDER 263 0.0133
149 PSEUDOMONAS INFECTION 113 0.0132
150 GENE MUTATION 26 0.0131
151 ADENOVIRUS INFECTION 38 0.0131
152 FOOD POISONING 70 0.0131
153 SALMONELLOSIS 22 0.0130
154 HAEMOLYSIS 99 0.0128
155 WEIGHT FLUCTUATION 134 0.0128
156 TRANSPLANT REJECTION 102 0.0127
157 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 25 0.0127
158 HYPOPROTEINAEMIA 24 0.0126
159 INFUSION RELATED REACTION 830 0.0125
160 ARTHROPOD BITE 92 0.0124
161 COVID-19 2175 0.0124
162 LYMPHADENITIS 30 0.0124
163 ORAL INFECTION 48 0.0123
164 SKIN ABRASION 58 0.0123
165 BREAST DISORDER 25 0.0122
166 PNEUMONIA FUNGAL 48 0.0122
167 INFECTIOUS MONONUCLEOSIS 27 0.0120
168 ILLNESS 1228 0.0119
169 AUTOIMMUNE THYROIDITIS 45 0.0119
170 ANTIPHOSPHOLIPID SYNDROME 19 0.0118
171 FINE MOTOR SKILL DYSFUNCTION 34 0.0117
172 HYPERVOLAEMIA 58 0.0117
173 EYE INFECTION 130 0.0115
174 INABILITY TO AFFORD MEDICATION 114 0.0115
175 KIDNEY INFECTION 225 0.0115
176 ELECTRIC SHOCK SENSATION 32 0.0114
177 PHOTOPHOBIA 214 0.0114
178 OXYGEN SATURATION ABNORMAL 32 0.0113
179 PARANASAL SINUS DISCOMFORT 42 0.0111
180 ANTINUCLEAR ANTIBODY POSITIVE 36 0.0111
181 SUSPECTED OFF LABEL USE 50 0.0111
182 GASTRIC INFECTION 42 0.0110
183 ALTERED STATE OF CONSCIOUSNESS 237 0.0109
184 ADRENAL DISORDER 21 0.0109
185 MENINGITIS 72 0.0108
186 FOOD ALLERGY 83 0.0107
187 GUILLAIN-BARRE SYNDROME 52 0.0107
188 BRONCHITIS 789 0.0106
189 FOETAL GROWTH RESTRICTION 64 0.0105
190 FOOT OPERATION 52 0.0105
191 OBESITY 167 0.0105
192 LIMB MASS 23 0.0105
193 THERAPY NON-RESPONDER 470 0.0104
194 PNEUMONIA VIRAL 33 0.0103
195 POST PROCEDURAL INFECTION 84 0.0103
196 PNEUMONIA CYTOMEGALOVIRAL 20 0.0103
197 C-REACTIVE PROTEIN ABNORMAL 66 0.0103
198 DIPLOPIA 267 0.0103
199 POSTOPERATIVE WOUND INFECTION 69 0.0102
200 VEIN DISORDER 51 0.0102
201 CHRONIC LYMPHOCYTIC LEUKAEMIA 48 0.0101
202 ATYPICAL PNEUMONIA 30 0.0100
203 INFUSION SITE INFECTION 23 0.0099
204 CANDIDA INFECTION 165 0.0098
205 LOCALISED INFECTION 229 0.0095
206 SINUS PAIN 22 0.0094
207 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 20 0.0094
208 JOINT INJURY 198 0.0093
209 AUTONOMIC NERVOUS SYSTEM IMBALANCE 27 0.0092
210 ESCHERICHIA INFECTION 76 0.0092
211 HAEMATEMESIS 232 0.0091
212 TENDERNESS 94 0.0090
213 POTENTIATING DRUG INTERACTION 30 0.0089
214 CATHETER SITE PAIN 23 0.0089
215 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1589 0.0088
216 HORDEOLUM 38 0.0088
217 INJECTION SITE DISCHARGE 47 0.0087
218 CUSHINGOID 28 0.0087
219 PRESYNCOPE 211 0.0087
220 BRAIN FOG 136 0.0087
221 CYTOMEGALOVIRUS INFECTION 144 0.0087
222 ABDOMINAL INFECTION 22 0.0086
223 LIMB INJURY 231 0.0085
224 BACTERIAL INFECTION 158 0.0085
225 SYNOVITIS 152 0.0084
226 PRODUCT SUPPLY ISSUE 60 0.0084
227 LIQUID PRODUCT PHYSICAL ISSUE 61 0.0084
228 INFECTION 1208 0.0083
229 WALKING AID USER 55 0.0083
230 GASTROINTESTINAL TOXICITY 40 0.0083
231 RED BLOOD CELL SEDIMENTATION RATE INCREASED 91 0.0082
232 SINUS CONGESTION 111 0.0082
233 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 78 0.0082
234 ASCITES 240 0.0082
235 FOOT DEFORMITY 90 0.0081
236 THROMBOTIC MICROANGIOPATHY 79 0.0081
237 FOETAL DEATH 42 0.0081
238 BLOOD PRESSURE SYSTOLIC ABNORMAL 20 0.0081
239 ENTEROCOCCAL INFECTION 39 0.0081
240 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 41 0.0080
241 CONCUSSION 62 0.0080
242 HYPOCALCAEMIA 151 0.0080
243 ENCEPHALITIS 55 0.0079
244 RHINITIS 64 0.0079
245 BLOOD IRON DECREASED 94 0.0079
246 NEEDLE ISSUE 229 0.0079
247 PARANASAL SINUS HYPERSECRETION 30 0.0079
248 RECURRENT CANCER 32 0.0078
249 BLOOD LACTIC ACID INCREASED 41 0.0078
250 PULMONARY FIBROSIS 149 0.0078
251 ARTHRITIS INFECTIVE 36 0.0078
252 TOOTH ABSCESS 79 0.0078
253 CREPITATIONS 23 0.0077
254 KIDNEY TRANSPLANT REJECTION 37 0.0077
255 BK VIRUS INFECTION 26 0.0077
256 JOINT EFFUSION 53 0.0077
257 PEMPHIGUS 96 0.0077
258 NODULE 99 0.0076
259 BLOOD PRESSURE ABNORMAL 149 0.0075
260 BLOOD PRESSURE SYSTOLIC DECREASED 34 0.0075
261 FUNGAL INFECTION 249 0.0075
262 ABDOMINAL MASS 20 0.0075
263 CYSTITIS 237 0.0074
264 PREGNANCY 149 0.0074
265 FOOT FRACTURE 140 0.0074
266 CHILLS 860 0.0073
267 ORAL FUNGAL INFECTION 20 0.0073
268 LIGAMENT SPRAIN 72 0.0073
269 PNEUMOCYSTIS JIROVECII PNEUMONIA 73 0.0073
270 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 212 0.0072
271 PRODUCT AVAILABILITY ISSUE 164 0.0072
272 LOWER RESPIRATORY TRACT INFECTION 324 0.0071
273 SENSITIVE SKIN 52 0.0070
274 SERUM FERRITIN INCREASED 37 0.0070
275 PHARYNGITIS 87 0.0070
276 INFLUENZA 776 0.0070
277 PYODERMA GANGRENOSUM 25 0.0069
278 HAND FRACTURE 49 0.0069
279 TACHYPNOEA 94 0.0069
280 LEUKAEMIA 65 0.0069
281 PARTIAL SEIZURES 36 0.0069
282 POST PROCEDURAL COMPLICATION 132 0.0069
283 FIBROMYALGIA 166 0.0068
284 SEPTIC SHOCK 296 0.0068
285 SYSTEMIC LUPUS ERYTHEMATOSUS 241 0.0068
286 HAND DEFORMITY 89 0.0068
287 URINARY TRACT INFECTION 1155 0.0068
288 RESPIRATORY RATE INCREASED 60 0.0068
289 VIRAL UPPER RESPIRATORY TRACT INFECTION 32 0.0067
290 KLEBSIELLA INFECTION 34 0.0067
291 HAEMATURIA 226 0.0066
292 PRODUCT LEAKAGE 37 0.0066
293 UPPER-AIRWAY COUGH SYNDROME 54 0.0065
294 MASTICATION DISORDER 20 0.0065
295 SCAR 111 0.0065
296 THERAPY PARTIAL RESPONDER 101 0.0065
297 MULTIPLE ORGAN DYSFUNCTION SYNDROME 183 0.0065
298 STAPHYLOCOCCAL BACTERAEMIA 28 0.0064
299 FUNGAL SKIN INFECTION 26 0.0064
300 MUSCULOSKELETAL DISCOMFORT 110 0.0064
301 PRODUCT DOSE OMISSION ISSUE 1870 0.0064
302 MUSCLE STRAIN 55 0.0064
303 CLOSTRIDIUM DIFFICILE INFECTION 138 0.0063
304 FEAR OF INJECTION 45 0.0063
305 SPLENOMEGALY 72 0.0061
306 BACTERIAL SEPSIS 20 0.0061
307 EAR DISORDER 28 0.0061
308 BLINDNESS 249 0.0061
309 ABSCESS LIMB 26 0.0061
310 STAPHYLOCOCCAL INFECTION 201 0.0061
311 SEPSIS 677 0.0061
312 FACE INJURY 23 0.0061
313 SKIN INJURY 20 0.0060
314 NASOPHARYNGITIS 1109 0.0060
315 PLATELET COUNT ABNORMAL 36 0.0059
316 BLOOD PRESSURE INCREASED 909 0.0059
317 PNEUMONIA 1924 0.0059
318 ARTHRITIS 466 0.0059
319 LIMB DISCOMFORT 183 0.0059
320 BLOOD MAGNESIUM DECREASED 51 0.0059
321 BODY TEMPERATURE INCREASED 119 0.0058
322 EYELID PTOSIS 59 0.0058
323 LYMPHOMA 89 0.0058
324 WOUND INFECTION 63 0.0057
325 INCORRECT PRODUCT ADMINISTRATION DURATION 123 0.0057
326 BRONCHOPULMONARY ASPERGILLOSIS 44 0.0057
327 TACHYCARDIA 504 0.0057
328 PRODUCTIVE COUGH 270 0.0057
329 COMA 269 0.0056
330 PERIPHERAL VENOUS DISEASE 23 0.0056
331 TUMOUR MARKER INCREASED 27 0.0056
332 VULVOVAGINAL PAIN 27 0.0056
333 PULMONARY THROMBOSIS 61 0.0056
334 HYPOALBUMINAEMIA 43 0.0055
335 MENISCUS INJURY 34 0.0055
336 BODY HEIGHT DECREASED 59 0.0055
337 PULMONARY TOXICITY 39 0.0055
338 OBSTRUCTIVE AIRWAYS DISORDER 61 0.0055
339 THYROID MASS 21 0.0055
340 CYTOPENIA 67 0.0055
341 MYOSITIS 49 0.0055
342 CELLULITIS 274 0.0054
343 DIVERTICULITIS 150 0.0054
344 MIGRAINE 515 0.0054
345 HEART RATE ABNORMAL 30 0.0054
346 HELICOBACTER INFECTION 55 0.0053
347 BACK INJURY 58 0.0053
348 HYPERTRANSAMINASAEMIA 37 0.0053
349 CARDIO-RESPIRATORY ARREST 221 0.0053
350 TINNITUS 240 0.0052
351 SINUS HEADACHE 31 0.0052
352 BACK DISORDER 84 0.0052
353 CARDIAC FAILURE CHRONIC 22 0.0052
354 RESPIRATORY TRACT CONGESTION 82 0.0052
355 OFF LABEL USE 4507 0.0051
356 THERAPEUTIC PRODUCT EFFECT DECREASED 230 0.0051
357 ARTHRITIS BACTERIAL 21 0.0051
358 FULL BLOOD COUNT ABNORMAL 54 0.0051
359 OROPHARYNGEAL DISCOMFORT 46 0.0051
360 OESOPHAGEAL CANDIDIASIS 20 0.0050
361 PARONYCHIA 22 0.0050
362 EYE PAIN 282 0.0050
363 HEPATITIS B 30 0.0050
364 CONJUNCTIVITIS 92 0.0050
365 RIB FRACTURE 102 0.0050
366 CONTRAINDICATED PRODUCT ADMINISTERED 150 0.0049
367 EAR PAIN 96 0.0049
368 IMPAIRED GASTRIC EMPTYING 67 0.0049
369 POLYP 32 0.0049
370 NERVE COMPRESSION 45 0.0049
371 HYPOKALAEMIA 225 0.0049
372 PAPILLOEDEMA 22 0.0049
373 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 40 0.0048
374 WRIST FRACTURE 58 0.0048
375 MONOPLEGIA 21 0.0048
376 GINGIVITIS 26 0.0048
377 GASTROINTESTINAL DISORDER 430 0.0048
378 HYPOXIA 168 0.0048
379 UROSEPSIS 44 0.0048
380 PULMONARY MASS 71 0.0048
381 BREAST MASS 32 0.0048
382 SYNOVIAL CYST 22 0.0048
383 ROTATOR CUFF SYNDROME 61 0.0047
384 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
385 MASS 66 0.0047
386 ARTHROPATHY 262 0.0047
387 OSTEOMYELITIS 85 0.0047
388 COMPRESSION FRACTURE 25 0.0047
389 BACTERAEMIA 55 0.0046
390 ORAL CANDIDIASIS 61 0.0046
391 SARCOIDOSIS 22 0.0046
392 ASTHMA 523 0.0046
393 CATARACT 275 0.0046
394 HERPES ZOSTER 265 0.0046
395 THYROID DISORDER 71 0.0046
396 LYMPHADENOPATHY 163 0.0046
397 HERNIA 89 0.0046
398 LUMBAR VERTEBRAL FRACTURE 21 0.0046
399 PRODUCT USE ISSUE 857 0.0046
400 PLEURISY 27 0.0045
401 IMMUNOSUPPRESSION 40 0.0045
402 CONTUSION 436 0.0045
403 SCIATICA 72 0.0045
404 NEPHROLITHIASIS 207 0.0045
405 THERMAL BURN 32 0.0045
406 ENDOCARDITIS 23 0.0045
407 LUNG DISORDER 219 0.0045
408 MALABSORPTION 23 0.0044
409 PYREXIA 1514 0.0044
410 SENSITIVITY TO WEATHER CHANGE 23 0.0044
411 PELVIC FRACTURE 34 0.0044
412 AUTISM SPECTRUM DISORDER 24 0.0044
413 BLADDER DISORDER 43 0.0043
414 GRAFT VERSUS HOST DISEASE 31 0.0043
415 BURSITIS 52 0.0043
416 REBOUND EFFECT 48 0.0042
417 SPINAL DISORDER 40 0.0042
418 ATAXIA 50 0.0042
419 FRUSTRATION TOLERANCE DECREASED 34 0.0042
420 BLOOD TEST ABNORMAL 59 0.0042
421 HYPOPHOSPHATAEMIA 31 0.0042
422 LYMPHOEDEMA 29 0.0042
423 SPINAL FRACTURE 84 0.0042
424 CYST 52 0.0042
425 PRODUCT USE COMPLAINT 66 0.0042
426 TOXIC EPIDERMAL NECROLYSIS 63 0.0041
427 COAGULOPATHY 69 0.0041
428 OROPHARYNGEAL PAIN 383 0.0041
429 FALL 1375 0.0041
430 INTRACRANIAL PRESSURE INCREASED 23 0.0041
431 HEAD INJURY 130 0.0041
432 INTENTIONAL PRODUCT USE ISSUE 359 0.0041
433 PHARYNGEAL SWELLING 40 0.0041
434 OXYGEN SATURATION DECREASED 229 0.0041
435 GLOSSODYNIA 91 0.0041
436 NORMAL NEWBORN 22 0.0040
437 CYTOKINE RELEASE SYNDROME 81 0.0040
438 NEURALGIA 98 0.0040
439 BLOOD PRESSURE DECREASED 267 0.0040
440 HERPES SIMPLEX 26 0.0040
441 UPPER LIMB FRACTURE 79 0.0040
442 FLANK PAIN 37 0.0039
443 TREATMENT FAILURE 327 0.0039
444 DRY THROAT 40 0.0039
445 FACIAL PAIN 35 0.0039
446 LOWER LIMB FRACTURE 75 0.0039
447 SKIN CANCER 84 0.0039
448 ROAD TRAFFIC ACCIDENT 163 0.0039
449 NEOPLASM MALIGNANT 260 0.0039
450 DRUG INTOLERANCE 376 0.0039
451 SNEEZING 87 0.0039
452 COUGH 1087 0.0039
453 PROCEDURAL PAIN 107 0.0039
454 FAECES SOFT 28 0.0038
455 RESPIRATORY DISORDER 115 0.0038
456 PNEUMONIA ASPIRATION 96 0.0038
457 ANAPHYLACTIC REACTION 212 0.0038
458 PETECHIAE 40 0.0038
459 PREMATURE DELIVERY 61 0.0038
460 LOW BIRTH WEIGHT BABY 30 0.0038
461 C-REACTIVE PROTEIN INCREASED 137 0.0038
462 SKIN MASS 25 0.0037
463 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
464 ENERGY INCREASED 22 0.0037
465 QUALITY OF LIFE DECREASED 50 0.0037
466 PREMATURE BABY 112 0.0037
467 STATUS EPILEPTICUS 42 0.0037
468 WHEEZING 219 0.0037
469 HEADACHE 2311 0.0037
470 PARAESTHESIA ORAL 53 0.0037
471 DECREASED IMMUNE RESPONSIVENESS 36 0.0037
472 FOETAL EXPOSURE DURING PREGNANCY 298 0.0037
473 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 259 0.0036
474 IRRITABLE BOWEL SYNDROME 78 0.0036
475 OEDEMA 197 0.0036
476 TOOTH FRACTURE 40 0.0036
477 POOR QUALITY SLEEP 78 0.0036
478 HYPERTRIGLYCERIDAEMIA 21 0.0036
479 INTERMENSTRUAL BLEEDING 20 0.0036
480 GASTRIC ULCER 68 0.0036
481 OSTEOPOROSIS 147 0.0036
482 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 186 0.0036
483 SCOLIOSIS 22 0.0035
484 GINGIVAL PAIN 28 0.0035
485 HIP FRACTURE 113 0.0035
486 MALAISE 1535 0.0035
487 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
488 RESPIRATORY FAILURE 252 0.0035
489 NECK PAIN 193 0.0034
490 MATERNAL EXPOSURE DURING PREGNANCY 307 0.0034
491 HEPATOTOXICITY 76 0.0034
492 DEVICE OCCLUSION 48 0.0034
493 HYPERAESTHESIA 28 0.0034
494 PLEURAL EFFUSION 207 0.0034
495 LYMPHOCYTE COUNT DECREASED 60 0.0034
496 GLUCOSE TOLERANCE IMPAIRED 20 0.0034
497 COMPLICATION ASSOCIATED WITH DEVICE 49 0.0034
498 CARPAL TUNNEL SYNDROME 47 0.0034
499 NICOTINE DEPENDENCE 26 0.0033
500 BLOOD SODIUM DECREASED 63 0.0033
501 SYMPTOM RECURRENCE 20 0.0033
502 NASAL CONGESTION 195 0.0033
503 JOINT DISLOCATION 35 0.0033
504 ASPIRATION 36 0.0033
505 ULCER 52 0.0033
506 BODY TEMPERATURE DECREASED 32 0.0032
507 CEREBRAL DISORDER 24 0.0032
508 PYELONEPHRITIS 28 0.0032
509 FATIGUE 2502 0.0032
510 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 154 0.0032
511 WEIGHT DECREASED 891 0.0032
512 GASTROINTESTINAL INFLAMMATION 25 0.0032
513 LYMPHOPENIA 45 0.0032
514 VASCULITIS 37 0.0032
515 SWELLING 297 0.0032
516 PNEUMOTHORAX 50 0.0031
517 APHONIA 44 0.0031
518 THROMBOSIS 253 0.0031
519 PRODUCT USE IN UNAPPROVED INDICATION 779 0.0031
520 ATRIOVENTRICULAR BLOCK COMPLETE 21 0.0031
521 ORAL HERPES 61 0.0031
522 MUSCULAR WEAKNESS 355 0.0031
523 ANAL INCONTINENCE 28 0.0031
524 SYNCOPE 311 0.0031
525 CHEST DISCOMFORT 318 0.0031
526 ATRIOVENTRICULAR BLOCK 24 0.0031
527 INFLUENZA LIKE ILLNESS 255 0.0031
528 MOBILITY DECREASED 221 0.0031
529 PRODUCT DOSE OMISSION IN ERROR 87 0.0031
530 FEELING COLD 85 0.0031
531 THERAPY CHANGE 30 0.0030
532 PRODUCT PREPARATION ISSUE 20 0.0030
533 INJECTION SITE DISCOMFORT 32 0.0030
534 RHINORRHOEA 195 0.0030
535 WOUND 84 0.0030
536 PROCEDURAL COMPLICATION 23 0.0030
537 PRODUCT PRESCRIBING ISSUE 65 0.0030
538 ANKLE FRACTURE 46 0.0030
539 SYRINGE ISSUE 52 0.0030
540 IMMUNE SYSTEM DISORDER 39 0.0030
541 DUODENAL ULCER PERFORATION 22 0.0030
542 SPUTUM DISCOLOURED 28 0.0029
543 BRAIN NEOPLASM 27 0.0029
544 HIATUS HERNIA 38 0.0029
545 ELECTROLYTE IMBALANCE 34 0.0029
546 EXPOSURE DURING PREGNANCY 181 0.0029
547 COLITIS 110 0.0029
548 BACK PAIN 674 0.0029
549 PLATELET COUNT DECREASED 309 0.0029
550 HYPERSOMNIA 83 0.0029
551 SLEEP APNOEA SYNDROME 55 0.0029
552 TOOTH DISORDER 64 0.0029
553 NEOPLASM 33 0.0029
554 RESPIRATORY DISTRESS 79 0.0029
555 DECUBITUS ULCER 23 0.0028
556 PRODUCT ADMINISTRATION ERROR 57 0.0028
557 THERAPY INTERRUPTED 200 0.0028
558 ATELECTASIS 27 0.0028
559 DEVICE RELATED INFECTION 43 0.0028
560 ACUTE HEPATIC FAILURE 38 0.0028
561 MUSCULOSKELETAL CHEST PAIN 43 0.0028
562 EMPHYSEMA 28 0.0028
563 SQUAMOUS CELL CARCINOMA 26 0.0028
564 AORTIC ANEURYSM 21 0.0028
565 ABSCESS 44 0.0028
566 LIVE BIRTH 23 0.0027
567 BEDRIDDEN 36 0.0027
568 HEART RATE DECREASED 96 0.0027
569 GRIP STRENGTH DECREASED 24 0.0027
570 TRANSIENT ISCHAEMIC ATTACK 92 0.0027
571 INTERSTITIAL LUNG DISEASE 132 0.0027
572 PANCYTOPENIA 152 0.0027
573 SECRETION DISCHARGE 34 0.0027
574 SHOCK HAEMORRHAGIC 22 0.0027
575 PULMONARY EMBOLISM 256 0.0027
576 MYALGIA 458 0.0027
577 BRAIN INJURY 27 0.0027
578 CONDITION AGGRAVATED 816 0.0027
579 APPENDICITIS 25 0.0027
580 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
581 LOSS OF CONSCIOUSNESS 340 0.0027
582 TOOTHACHE 48 0.0026
583 BONE DENSITY DECREASED 83 0.0026
584 DRUG RESISTANCE 68 0.0026
585 ABDOMINAL PAIN 614 0.0026
586 GAIT INABILITY 88 0.0026
587 SKIN REACTION 37 0.0026
588 MYOCARDITIS 30 0.0026
589 DEEP VEIN THROMBOSIS 170 0.0026
590 INFLAMMATION 135 0.0026
591 NEUROPATHY PERIPHERAL 248 0.0026
592 PRESCRIBED UNDERDOSE 52 0.0026
593 ABDOMINAL DISTENSION 272 0.0026
594 ACUTE RESPIRATORY FAILURE 50 0.0026
595 RENAL DISORDER 121 0.0026
596 ACCIDENT 31 0.0026
597 FACIAL PARALYSIS 22 0.0026
598 FOLLICULITIS 27 0.0026
599 RHEUMATOID ARTHRITIS 292 0.0026
600 ABORTION SPONTANEOUS 103 0.0026
601 HEART RATE INCREASED 253 0.0026
602 RENAL PAIN 27 0.0025
603 HEPATOMEGALY 25 0.0025
604 LEUKOPENIA 127 0.0025
605 FURUNCLE 20 0.0025
606 ASTHENIA 948 0.0025
607 URINE OUTPUT DECREASED 22 0.0025
608 HEREDITARY ANGIOEDEMA 27 0.0025
609 BLOOD PRESSURE SYSTOLIC INCREASED 49 0.0025
610 SOMNOLENCE 505 0.0025
611 ATRIAL FLUTTER 20 0.0025
612 NEPHROPATHY TOXIC 28 0.0025
613 SPINAL PAIN 29 0.0025
614 SLUGGISHNESS 25 0.0024
615 COELIAC DISEASE 24 0.0024
616 HAEMATOMA 63 0.0024
617 MYOPATHY 21 0.0024
618 NERVE INJURY 27 0.0024
619 POLYNEUROPATHY 29 0.0024
620 WEIGHT INCREASED 542 0.0024
621 GALLBLADDER DISORDER 43 0.0024
622 THROAT IRRITATION 108 0.0024
623 COLD SWEAT 42 0.0024
624 BRONCHOSPASM 34 0.0024
625 PERICARDIAL EFFUSION 55 0.0024
626 LUNG INFILTRATION 21 0.0024
627 PERIPHERAL SWELLING 366 0.0024
628 CARDIOGENIC SHOCK 34 0.0024
629 THROMBOCYTOPENIA 264 0.0024
630 CLOSTRIDIUM DIFFICILE COLITIS 25 0.0024
631 SHOCK 54 0.0023
632 GASTROOESOPHAGEAL REFLUX DISEASE 187 0.0023
633 SKIN ULCER 60 0.0023
634 ACUTE RESPIRATORY DISTRESS SYNDROME 41 0.0023
635 LUPUS-LIKE SYNDROME 21 0.0023
636 JOINT RANGE OF MOTION DECREASED 31 0.0023
637 CARDIOMYOPATHY 34 0.0023
638 DRUG EFFECT LESS THAN EXPECTED 34 0.0023
639 MUSCULOSKELETAL STIFFNESS 201 0.0023
640 INTERVERTEBRAL DISC PROTRUSION 50 0.0023
641 INCREASED TENDENCY TO BRUISE 21 0.0023
642 SKIN DISORDER 76 0.0023
643 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
644 URTICARIA 381 0.0023
645 HAEMORRHAGE INTRACRANIAL 34 0.0023
646 FEEDING DISORDER 46 0.0023
647 ARTHRALGIA 942 0.0023
648 EPISTAXIS 168 0.0022
649 HYPERTENSION 471 0.0022
650 RASH PRURITIC 120 0.0022
651 JOINT STIFFNESS 58 0.0022
652 DYSPNOEA 1246 0.0022
653 DIABETES MELLITUS 167 0.0022
654 DYSPHONIA 128 0.0022
655 SEIZURE 252 0.0022
656 VENTRICULAR TACHYCARDIA 36 0.0022
657 GOUT 39 0.0022
658 VOMITING 1019 0.0022
659 BLOOD CALCIUM INCREASED 19 0.0022
660 BLOOD PRESSURE FLUCTUATION 52 0.0022
661 VERTIGO 132 0.0022
662 EATING DISORDER 46 0.0022
663 RASH MACULAR 75 0.0021
664 THROAT TIGHTNESS 58 0.0021
665 RASH PAPULAR 48 0.0021
666 BRAIN OEDEMA 27 0.0021
667 KNEE ARTHROPLASTY 45 0.0021
668 NEUTROPHIL COUNT DECREASED 87 0.0021
669 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
670 PAIN 1308 0.0021
671 HEPATIC ENZYME INCREASED 145 0.0021
672 SARS-COV-2 TEST POSITIVE 28 0.0021
673 BASAL CELL CARCINOMA 33 0.0021
674 NERVOUS SYSTEM DISORDER 66 0.0021
675 SPINAL OPERATION 26 0.0021
676 INTERNAL HAEMORRHAGE 24 0.0021
677 AGRANULOCYTOSIS 39 0.0021
678 VISION BLURRED 286 0.0021
679 PLASMA CELL MYELOMA 81 0.0021
680 PRESCRIBED OVERDOSE 40 0.0021
681 NAUSEA 1634 0.0021
682 BLOOD URINE PRESENT 39 0.0021
683 CARDIAC DISORDER 192 0.0021
684 LETHARGY 118 0.0020
685 INJECTION SITE IRRITATION 26 0.0020
686 HYPERSENSITIVITY 379 0.0020
687 IMPAIRED HEALING 67 0.0020
688 FULL BLOOD COUNT DECREASED 41 0.0020
689 ABDOMINAL DISCOMFORT 341 0.0020
690 SMALL INTESTINAL OBSTRUCTION 25 0.0020
691 PAIN IN EXTREMITY 597 0.0020
692 INJECTION SITE SWELLING 155 0.0020
693 MALIGNANT MELANOMA 27 0.0020
694 FEELING ABNORMAL 479 0.0020
695 DIZZINESS 994 0.0020
696 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 51 0.0020
697 WHITE BLOOD CELL COUNT INCREASED 76 0.0020
698 SKIN LESION 54 0.0020
699 FLUID RETENTION 100 0.0020
700 ATRIAL FIBRILLATION 191 0.0020
701 DYSMENORRHOEA 26 0.0020
702 THERAPEUTIC RESPONSE SHORTENED 65 0.0020
703 MENTAL DISORDER 85 0.0020
704 DRUG INEFFECTIVE 2572 0.0019
705 INJECTION SITE MASS 72 0.0019
706 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
707 PRURITUS 747 0.0019
708 ABDOMINAL PAIN UPPER 400 0.0019
709 PHOTOSENSITIVITY REACTION 32 0.0019
710 HAEMOPTYSIS 54 0.0019
711 ECZEMA 101 0.0019
712 PALLOR 52 0.0019
713 ILL-DEFINED DISORDER 116 0.0019
714 BLISTER 107 0.0019
715 PERICARDITIS 32 0.0019
716 DEHYDRATION 254 0.0019
717 GINGIVAL BLEEDING 26 0.0019
718 DYSPHAGIA 180 0.0019
719 MUSCLE ATROPHY 24 0.0019
720 PERIPHERAL COLDNESS 26 0.0019
721 DYSPNOEA EXERTIONAL 71 0.0019
722 HEPATITIS 48 0.0019
723 PULMONARY HYPERTENSION 39 0.0019
724 INTESTINAL PERFORATION 21 0.0019
725 RESTLESS LEGS SYNDROME 34 0.0019
726 TENDON RUPTURE 23 0.0019
727 HEPATIC CIRRHOSIS 35 0.0019
728 MYELOSUPPRESSION 67 0.0019
729 HAEMOGLOBIN DECREASED 191 0.0019
730 EYE DISORDER 61 0.0019
731 CHEST PAIN 342 0.0018
732 SCAB 21 0.0018
733 HYPOTENSION 369 0.0018
734 LIVER INJURY 45 0.0018
735 BLOOD POTASSIUM DECREASED 55 0.0018
736 DERMATITIS ALLERGIC 23 0.0018
737 HEPATIC STEATOSIS 34 0.0018
738 LIVER FUNCTION TEST ABNORMAL 53 0.0018
739 PULMONARY CONGESTION 24 0.0018
740 COLON CANCER 27 0.0018
741 IMPAIRED QUALITY OF LIFE 26 0.0018
742 DRUG ERUPTION 32 0.0018
743 LIVER DISORDER 80 0.0018
744 POST PROCEDURAL HAEMORRHAGE 21 0.0018
745 DIARRHOEA 1155 0.0018
746 MALNUTRITION 20 0.0018
747 TASTE DISORDER 36 0.0018
748 EPILEPSY 54 0.0018
749 GLAUCOMA 34 0.0018
750 PSORIASIS 230 0.0018
751 MACULAR DEGENERATION 21 0.0018
752 WHITE BLOOD CELL COUNT DECREASED 190 0.0018
753 PSORIATIC ARTHROPATHY 71 0.0017
754 PARALYSIS 25 0.0017
755 SPEECH DISORDER 91 0.0017
756 DISEASE PROGRESSION 205 0.0017
757 HYPOAESTHESIA ORAL 26 0.0017
758 DEAFNESS 45 0.0017
759 DENTAL CARIES 19 0.0017
760 OSTEOPENIA 26 0.0017
761 DECREASED APPETITE 397 0.0017
762 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
763 DYSARTHRIA 64 0.0017
764 HIP ARTHROPLASTY 26 0.0017
765 TENDONITIS 26 0.0017
766 OSTEOARTHRITIS 71 0.0017
767 MEMORY IMPAIRMENT 229 0.0017
768 HYPOAESTHESIA 249 0.0017
769 ERYTHEMA 341 0.0017
770 UNDERDOSE 121 0.0017
771 HEMIPARESIS 28 0.0017
772 GAIT DISTURBANCE 316 0.0016
773 MOVEMENT DISORDER 53 0.0016
774 TREATMENT NONCOMPLIANCE 90 0.0016
775 GASTROENTERITIS 24 0.0016
776 CHROMATURIA 37 0.0016
777 ANAEMIA 312 0.0016
778 HAEMORRHAGE 171 0.0016
779 DERMATITIS 34 0.0016
780 DISEASE RECURRENCE 77 0.0016
781 TREMOR 268 0.0016
782 PLATELET COUNT INCREASED 21 0.0016
783 DEMENTIA 45 0.0016
784 DEPRESSED MOOD 85 0.0016
785 INSOMNIA 427 0.0016
786 INCORRECT DOSE ADMINISTERED 363 0.0016
787 DISCOMFORT 97 0.0016
788 SKIN FISSURES 31 0.0016
789 FLUSHING 161 0.0016
790 ORAL DISCOMFORT 22 0.0016
791 RENAL IMPAIRMENT 133 0.0016
792 RED BLOOD CELL COUNT DECREASED 45 0.0016
793 GENERALISED TONIC-CLONIC SEIZURE 26 0.0016
794 MOUTH ULCERATION 33 0.0016
795 INTESTINAL OBSTRUCTION 59 0.0016
796 NEUTROPENIA 212 0.0016
797 FEBRILE NEUTROPENIA 103 0.0016
798 GENERAL PHYSICAL HEALTH DETERIORATION 178 0.0015
799 CIRCULATORY COLLAPSE 26 0.0015
800 INJECTION SITE PRURITUS 102 0.0015
801 ORAL PAIN 34 0.0015
802 RASH 661 0.0015
803 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
804 ANGIOEDEMA 67 0.0015
805 PANIC ATTACK 55 0.0015
806 ENCEPHALOPATHY 37 0.0015
807 BALANCE DISORDER 129 0.0015
808 LEUKOCYTOSIS 27 0.0015
809 APHASIA 45 0.0015
810 CHOKING 29 0.0015
811 PAIN IN JAW 42 0.0015
812 GASTRITIS 39 0.0015
813 MUSCLE TIGHTNESS 24 0.0015
814 SWELLING FACE 96 0.0015
815 SWOLLEN TONGUE 46 0.0015
816 LIP SWELLING 49 0.0015
817 CYANOSIS 23 0.0015
818 JOINT SWELLING 175 0.0014
819 MENTAL IMPAIRMENT 35 0.0014
820 DELIRIUM 50 0.0014
821 METABOLIC ACIDOSIS 46 0.0014
822 HYPOMAGNESAEMIA 20 0.0014
823 MUSCLE SPASMS 263 0.0014
824 OSTEONECROSIS 47 0.0014
825 BLINDNESS UNILATERAL 20 0.0014
826 PARAESTHESIA 223 0.0014
827 FEELING JITTERY 27 0.0014
828 MUSCULOSKELETAL PAIN 74 0.0014
829 BLOOD GLUCOSE ABNORMAL 26 0.0014
830 CHOLELITHIASIS 46 0.0014
831 SLEEP DISORDER 99 0.0014
832 DRUG-INDUCED LIVER INJURY 44 0.0014
833 HOSPITALISATION 215 0.0014
834 NIGHT SWEATS 45 0.0014
835 TYPE 2 DIABETES MELLITUS 47 0.0014
836 PNEUMONITIS 38 0.0014
837 TRANSAMINASES INCREASED 31 0.0014
838 DEVICE ISSUE 125 0.0014
839 COGNITIVE DISORDER 65 0.0014
840 NO ADVERSE EVENT 252 0.0014
841 MYELODYSPLASTIC SYNDROME 20 0.0014
842 BRADYCARDIA 73 0.0014
843 INJURY ASSOCIATED WITH DEVICE 28 0.0014
844 FEELING HOT 84 0.0014
845 PANCREATITIS 72 0.0014
846 INJECTION SITE ERYTHEMA 168 0.0014
847 INJECTION SITE BRUISING 107 0.0013
848 HAEMORRHOIDS 26 0.0013
849 RENAL FAILURE 176 0.0013
850 DISABILITY 26 0.0013
851 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
852 SKIN DISCOLOURATION 60 0.0013
853 HEPATIC FAILURE 39 0.0013
854 EYE SWELLING 48 0.0013
855 ANXIETY 361 0.0013
856 ARRHYTHMIA 60 0.0013
857 HEPATIC FUNCTION ABNORMAL 47 0.0013
858 RASH ERYTHEMATOUS 60 0.0013
859 PALPITATIONS 146 0.0012
860 CARDIAC ARREST 102 0.0012
861 ISCHAEMIC STROKE 22 0.0012
862 CEREBRAL HAEMORRHAGE 44 0.0012
863 JAUNDICE 33 0.0012
864 PRODUCT PRESCRIBING ERROR 29 0.0012
865 MULTIPLE FRACTURES 20 0.0012
866 URINARY INCONTINENCE 36 0.0012
867 BLOOD CREATININE INCREASED 79 0.0012
868 DRY MOUTH 98 0.0012
869 DEVICE BREAKAGE 49 0.0012
870 DRUG INTERACTION 191 0.0012
871 DEVICE LEAKAGE 52 0.0012
872 BONE PAIN 70 0.0012
873 VISUAL IMPAIRMENT 146 0.0012
874 BLOOD POTASSIUM INCREASED 19 0.0012
875 BURNING SENSATION 82 0.0012
876 RASH MACULO-PAPULAR 26 0.0012
877 ANAPHYLACTIC SHOCK 30 0.0012
878 FEMUR FRACTURE 36 0.0012
879 GASTROINTESTINAL HAEMORRHAGE 96 0.0011
880 NERVOUSNESS 60 0.0011
881 CARDIAC FAILURE 92 0.0011
882 CEREBROVASCULAR ACCIDENT 194 0.0011
883 CONSTIPATION 249 0.0011
884 LACRIMATION INCREASED 34 0.0011
885 HAEMATOCHEZIA 62 0.0011
886 DEATH 967 0.0011
887 DRY EYE 56 0.0011
888 CARDIAC FAILURE CONGESTIVE 90 0.0011
889 LIVER FUNCTION TEST INCREASED 24 0.0011
890 HYPOACUSIS 48 0.0011
891 POLLAKIURIA 46 0.0011
892 ACUTE KIDNEY INJURY 168 0.0011
893 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37 0.0011
894 HYPERHIDROSIS 141 0.0011
895 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
896 ADVERSE DRUG REACTION 98 0.0011
897 OEDEMA PERIPHERAL 132 0.0011
898 ABDOMINAL PAIN LOWER 27 0.0011
899 HEART RATE IRREGULAR 24 0.0011
900 BONE DISORDER 19 0.0010
901 EYE PRURITUS 35 0.0010
902 HYPOTHYROIDISM 33 0.0010
903 CEREBRAL INFARCTION 25 0.0010
904 CRYING 37 0.0010
905 INTENTIONAL DOSE OMISSION 29 0.0010
906 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
907 DYSPEPSIA 98 0.0010
908 PRODUCT PHYSICAL ISSUE 20 0.0010
909 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 46 0.0010
910 COLITIS ULCERATIVE 44 0.0010
911 LABORATORY TEST ABNORMAL 29 0.0010
912 INJECTION SITE HAEMORRHAGE 78 0.0010
913 ALOPECIA 189 0.0010
914 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
915 RESTLESSNESS 35 0.0010
916 STOMATITIS 58 0.0010
917 MUCOSAL INFLAMMATION 25 0.0010
918 NEOPLASM PROGRESSION 33 0.0009
919 IRRITABILITY 57 0.0009
920 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
921 STEVENS-JOHNSON SYNDROME 21 0.0009
922 CONFUSIONAL STATE 151 0.0009
923 PULMONARY OEDEMA 41 0.0009
924 MUSCLE TWITCHING 21 0.0009
925 MELAENA 20 0.0009
926 MYOCARDIAL INFARCTION 158 0.0009
927 MENTAL STATUS CHANGES 25 0.0009
928 DYSURIA 33 0.0009
929 SKIN IRRITATION 41 0.0009
930 DYSSTASIA 26 0.0009
931 BLOOD BILIRUBIN INCREASED 24 0.0009
932 SURGERY 52 0.0009
933 ACUTE MYOCARDIAL INFARCTION 26 0.0009
934 LUNG NEOPLASM MALIGNANT 36 0.0009
935 RECTAL HAEMORRHAGE 37 0.0009
936 BREAST CANCER 80 0.0009
937 THERAPY CESSATION 44 0.0009
938 PRODUCT STORAGE ERROR 75 0.0009
939 URINARY RETENTION 28 0.0008
940 MULTIPLE SCLEROSIS 40 0.0008
941 DISTURBANCE IN ATTENTION 45 0.0008
942 THERAPEUTIC RESPONSE DECREASED 50 0.0008
943 BREAST CANCER FEMALE 22 0.0008
944 BLOOD CHOLESTEROL INCREASED 38 0.0008
945 OCULAR HYPERAEMIA 38 0.0008
946 FLATULENCE 45 0.0008
947 MEDICATION ERROR 44 0.0008
948 AMNESIA 51 0.0008
949 INJURY 55 0.0008
950 DISORIENTATION 31 0.0008
951 BLOOD GLUCOSE DECREASED 37 0.0008
952 PSYCHOTIC DISORDER 22 0.0007
953 DEPRESSION 168 0.0007
954 DYSKINESIA 30 0.0007
955 INJECTION SITE PAIN 224 0.0007
956 GASTRIC DISORDER 25 0.0007
957 AGITATION 53 0.0007
958 MOOD SWINGS 23 0.0007
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 143 0.0007
960 HOT FLUSH 53 0.0007
961 INJECTION SITE REACTION 48 0.0007
962 INJECTION SITE RASH 21 0.0007
963 HYPONATRAEMIA 38 0.0007
964 EXTRA DOSE ADMINISTERED 26 0.0006
965 DEVICE DIFFICULT TO USE 42 0.0006
966 DRY SKIN 84 0.0006
967 EYE IRRITATION 36 0.0006
968 SKIN EXFOLIATION 52 0.0006
969 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
970 UNEVALUABLE EVENT 43 0.0006
971 HYPERGLYCAEMIA 20 0.0005
972 HALLUCINATION 41 0.0005
973 DEVICE DISLOCATION 22 0.0005
974 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
975 HYPOGLYCAEMIA 23 0.0005
976 DEVICE MALFUNCTION 33 0.0005
977 PRODUCT SUBSTITUTION ISSUE 26 0.0005
978 MALIGNANT NEOPLASM PROGRESSION 46 0.0004
979 ADVERSE EVENT 41 0.0004
980 PRODUCT QUALITY ISSUE 58 0.0004
981 CHRONIC KIDNEY DISEASE 32 0.0004
982 BLOOD GLUCOSE INCREASED 75 0.0004
983 SUICIDE ATTEMPT 22 0.0004
984 PROSTATE CANCER 28 0.0003
985 TOXICITY TO VARIOUS AGENTS 56 0.0003
986 DYSGEUSIA 24 0.0003
987 ACNE 22 0.0003
988 SUICIDAL IDEATION 22 0.0002
989 OVERDOSE 47 0.0002
990 EMOTIONAL DISTRESS 26 0.0002
991 DRUG DEPENDENCE 31 0.0002